A retrospective observational study to evaluate the efficacy of laparoscopic liver resection for small hepatocellular carcinoma located in the hepatic dome.

A retrospective observational study to evaluate the efficacy of laparoscopic liver resection for small hepatocellular carcinoma located in the hepatic dome. - Laparoscopic liver resection for small hepatocellular carcinoma located in the hepatic dome.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040758

Enrollment

1000

Registered

2020-06-15

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hepatocellular carcinoma patients who underwent open or laparoscopic radical resection in accordance with the following criteria 1) Any gender and age 2) Patients with solitary lesions of 5 cm or less, located in liver segments 2 to 6 where it is possible to perform partial hepatectomy and lateral segmentectomy, or Patients with solitary lesion of 3cm or less, located in segments 7 or 8 where it is possible to perform partial hepatectomy and subsegmentectomy. 3) The diagnoses of hepatocellular carcinoma were confirmed pathologically (including combined hepatocellular carcinoma and cholangiocellular carcinoma) 4) Hepatocellular carcinoma patients who underwent initial hepatectomy

Exclusion criteria

Exclusion criteria: 1) Hepatocellular carcinoma patients who had undergone following treatments for the target lesion -Percutaneous local ablative therapy (PEIT, RFA, MCT) -Transarterial (chemo) embolization -Radiation therapy 2) Hepatocellular carcinoma patients who underwent following procedure during the operation. -Vascular resection and reconstruction. -Tumor thrombectomy -Biliary reconstruction -Simultaneous resection of liver cancer and other internal organs, except the gallbladder -Local ablative therapy (PEIT, RFA, MCT) 3) Multiple liver lesion 4) Thoracoscopic surgery 5) Robotic-assisted surgery

Design outcomes

Primary

Measure	Time frame
Postoperative hospital stay	—

Secondary

Measure	Time frame
Intraoperative blood loss, operation time	—

Countries

Japan

Contacts

Public ContactYukio Tokumitsu

Yamaguchi University Graduate School of Medicine Department of Gastroenterological, Breast and Endocrine Surgery

yt790604@yamaguchi-u.ac.jp0836-22-2264

Outcome results